Evotec
Claire Levrier is a Senior Research Scientist and team leader in in vitro Oncology at Evotec, managing a multidisciplinary team and overseeing target validation and lead optimization in oncology. Previously, Claire served as a Senior Drug Discovery Scientist and Project Lead at UniQuest, focusing on in vitro and in vivo compound profiling for prostate cancer projects. Claire's extensive background includes postdoctoral research at Queensland University of Technology, a PhD in Natural Products Chemistry and Cancer Biology, and various research internships emphasizing phytochemical and pharmacological studies. Educational qualifications span degrees from Griffith University, University of Strasbourg, and L'Institut Agro Rennes-Angers, with additional training in pharmaceutical research commercialization.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.